Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

An AAV-CRISPR/Cas9 strategy for gene editing across divergent rodent species: Targeting neural oxytocin receptors as a proof of concept

Science Advances(2023)10.1126/sciadv.adf4950Source: DataRank Database

An AAV-CRISPR/Cas9 strategy for gene editing across divergent rodent species: Targeting neural oxytocin receptors as a proof of concept is a research paper published in Science Advances (2023). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Topics (5)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Marina Boon ORCID,H. Elliott Albers ORCID,Samantha R. Eck,Brandon A. Fricker ORCID,Aubrey M. Kelly ORCID

Live enrichment

PubMed:37256960 PMC:PMC10413677

NIMH NIH HHS

Grant: P50 MH100023

NIH HHS

Grant: P51 OD011132

NIMH NIH HHS

Grant: R21 MH114151

NIMH NIH HHS

Grant: R01 MH121829

NIMH NIH HHS

Grant: R01 MH112788

NIMH NIH HHS

Grant: R21 MH109302

MeSH Terms

AnimalsOxytocinReceptors, OxytocinCRISPR-Cas SystemsGene Editing